Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
AI In Life Science Analytics Market Size, Value And Growth Trends Through 2030
The AI in life science analytics market size has experienced rapid growth in recent years. It is projected to expand from $2.63 billion in 2025 to $3.13 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.0%. This historical growth can be attributed to factors like the increasing volume of clinical and research data, the expansion of digital clinical trials, the growing application of analytics in pharmaceutical r&d, the adoption of data-driven decision making in life sciences, and improvements in data integration technologies.
The AI in life science analytics market size is anticipated to experience significant expansion over the coming years, with projections indicating a rise to $6.16 billion by 2030, reflecting a compound annual growth rate (CAGR) of 18.4%. This growth during the forecast period is driven by several factors, including the escalating demand for precision diagnostics, increased investments in AI-enabled drug development, the wider adoption of cloud analytics, the growing application of real-world evidence analytics, and an intensified focus on operational efficiency across the life sciences industry. Noteworthy trends expected in the forecast period involve the expanded deployment of AI-based clinical analytics tools, the rising application of predictive modeling in drug discovery, the increasing uptake of cloud-based life science analytics, the proliferation of real-time data integration platforms, and a heightened emphasis on generating actionable insights.
Download A Free Sample Report For Comprehensive Market Insights:
AI In Life Science Analytics Market Opportunity Drivers: What Is Creating New Revenue Potential?
An anticipated increase in healthcare spending is set to drive the expansion of the AI in the life science analytics market in the coming period. Healthcare expenditure represents the aggregate funds allocated to medical products and services over a defined timeframe, covering expenses tied to medical interventions and public health efforts. The ascent in healthcare spending stems from the increasing incidence of chronic and lifestyle-induced ailments, necessitating prolonged therapies, continuous healthcare provision, and expensive procedures. This spending fuels the integration of AI in life science analytics through investment in sophisticated, data-powered instruments that enhance research effectiveness, improve patient results, and provide economical healthcare remedies. Illustratively, data from May 2024 published by the UK’s Office of National Statistics revealed that overall healthcare spending grew by 5.6% nominally between 2022 and 2023, a significant rise compared to the 0.9% growth recorded in 2022. Consequently, the upward trend in healthcare spending is a key factor propelling the expansion of the AI in the life science analytics market.
AI In Life Science Analytics Market Segment Analysis: What Are The Major Market Categories?
The AI in life science analytics market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment: On-Premise, Cloud
3) By Application: Research And Development, Sales And Marketing Support, Supply Chain Analytics, Other Applications
4) By End-User: Medical Devices, Pharmaceutical, Biotechnology, Other End Users
Subsegments:
1) By Software: Data Analysis Software, Predictive Analytics Tools, Machine Learning Platforms, Visualization Software, Clinical Trial Management Software
2) By Hardware: Servers, Storage Solutions, Workstations, Networking Equipment
3) By Services: Consulting Services, Integration Services, Support And Maintenance, Data Management Services, Training Services
AI In Life Science Analytics Market Industry Trends: What Changes Are Reshaping Demand?
Leading companies within the AI in Life Science Analytics market are prioritizing the development of innovative tools, such as AI-powered multi-omics data analysis platforms, to enhance the speed and accuracy of insights in biomedical research. These AI-empowered multi-omics data analysis platforms represent a technology leveraging artificial intelligence to integrate and interpret diverse biological data types, including genomics, proteomics, and metabolomics, thereby uncovering intricate biological understandings and facilitating precision medicine. As an illustration, in October 2023, BioLizard, a biotechnology firm based in Belgium, introduced its new AI-enabled BioVerse platform, designed to advance data-driven research and development for the worldwide life sciences sector. This platform is engineered to deliver customized, accessible software solutions that yield data-driven outcomes, catering to scientists in biotech and pharmaceutical fields, irrespective of their IT backgrounds. BioVerse comprises three key applications: Bio|Reflect, which offers comprehensive publication overviews to aid impartial literature searches; Pro|Biome, which applies data analytics to analyze microbiomes; and Bio|Mx, which utilizes AI for the integration and analysis of multi-omics datasets. The fundamental objective of BioVerse is to streamline data-driven discovery as well as preclinical, translational, and clinical R&D workflows within the life sciences industry by deploying AI-driven solutions. This introduction underscores BioLizard’s dedication to supplying AI-powered solutions that bolster data-driven discovery and the various R&D stages (preclinical, translational, and clinical) across the life sciences industry.
AI In Life Science Analytics Market Leading Companies Driving Competitive Growth
Major companies operating in the AI in life science analytics market are Indegene Limited; International Business Machines Corporation; IQVIA Holdings Inc.; Databricks Inc.; SAS Institute Inc.; Sorcero; Atomwise Inc.; Microsoft Corporation; NVIDIA Corporation; Oracle Corporation; NuMedii Inc.; Enlitic Inc.; Apixio Inc.; AiCure LLC; Google LLC; Amazon Web Services Inc.; Accenture; BioSymetrics; Cloud Pharmaceuticals; Freenome; GNS Healthcare; Insilico Medicine; PathAI; Recursion Pharmaceuticals; Sophia Genetics; Veracyte Inc.; Lexalytics Inc.; Sisense Inc.; Cognitivescale; Ayasdi; Cyrcadia Health
Access The Complete AI In Life Science Analytics Market Report:
#AI In Life Science Analytics Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the AI in life science analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the AI in life science analytics market report during the forecast period. The regions covered in the AI in life science analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
